Pure Global

Use of Nalpuphine in post operative pain - Trial PACTR201304000486309

Access comprehensive clinical trial information for PACTR201304000486309 through Pure Global AI's free database. This Not Applicable trial is sponsored by Dar El Foad Hospital; Amoun Pharmaceutical Company and is currently Not yet recruiting. The study focuses on Surgery; Other.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Pan Africa Clinical Trials Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
PACTR201304000486309
Not Applicable
Not yet recruiting
Trial Details
Pan Africa Clinical Trials Registry • PACTR201304000486309
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Use of Nalpuphine in post operative pain
Does Gender Affect the Response to the Use of Intravenous Nalbuphine for Post Operative Analgesia after Major Abdominal Surgery; A multicenter Study

Study Focus

Surgery; Other

Sponsor & Location

Dar El Foad Hospital; Amoun Pharmaceutical Company

Amoun Pharmaceutical Company

Egypt

Timeline & Enrollment

Not Applicable

Jan 01, 1900

Jan 01, 1900

Summary

The current study is designed to compare the effect of various doses of Nalbuphine used as continuous infusion for post operative pain control after major abdominal surgery between male and female gender.

ICD-10 Classifications

Other surgical procedures
Other medical procedures
Other reconstructive surgery
During other surgical and medical care
During other surgical and medical care

Data Source

Pan Africa Clinical Trials Registry

PACTR201304000486309

Non-Device Trial